This is a pivotal, interventional, prospective, single-arm, open-label, multi-site clinical investigation intended to support FDA clearance of the study device based on the safety and efficacy of the device in cannulating arteriovenous fistulas (AVFs) for hemodialysis procedures.
Dialysis; Complications, Vascular Access Complication
This is a pivotal, interventional, prospective, single-arm, open-label, multi-site clinical investigation intended to support FDA clearance of the study device based on the safety and efficacy of the device in cannulating arteriovenous fistulas (AVFs) for hemodialysis procedures.
Access Cannulation Trial II
-
Trinity Research Group, Dothan, Alabama, United States, 36301
Brigham and Women's Hospital, Boston, Massachusetts, United States, 02115
Fairlawn Surgery Center, Roanoke, Virginia, United States, 24014
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
18 Years to
ALL
No
Voyager Biomedical,
Stephen Hohmann, MD, PRINCIPAL_INVESTIGATOR, Baylor Scott and White Health
2027-03-25